This protocol is judged by an institutional review board, an impartial group that critiques any medical trials involving human beings. If a review entails a Plan I drug, when the board approves the protocol as moral, the scientists really have to apply for an investigational new drug (IND) amount with the FDA.“It’s essential to understand that